Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Next-Generation Stem Cell Therapy for Inflammation-Driven Degenerative Diseases with Ed Ahn MEDIPOST TRANSCRIPT

Download PDF

Mar 5, 2026

Ed Ahn, CEO of MEDIPOST, is developing next-generation stem cell therapies for inflammation-driven degenerative diseases with a primary focus on knee osteoarthritis. Using umbilical cord-derived stem cells, which have higher proliferation capacity than adult-derived stem cells, allows MEDIPOST to scale...

Read More

Next-Generation Stem Cell Therapy for Inflammation-Driven Degenerative Diseases with Ed Ahn MEDIPOST

Mar 5, 2026

Ed Ahn, CEO of MEDIPOST, is developing next-generation stem cell therapies for inflammation-driven degenerative diseases with a primary focus on knee osteoarthritis. Using umbilical cord-derived stem cells, which have higher proliferation capacity than adult-derived stem cells, allows MEDIPOST to scale...

Read More

Driving Innovation in Cell Therapy Manufacturing with Ryan Clarke Syntax Bio TRANSCRIPT

Download PDF

Feb 12, 2026

 Ryan Clarke, Co-Founder and CTO of Syntax Bio, is focused on solving manufacturing challenges in producing stem cell-derived therapies, specifically the process of stem cell differentiation. The Cellgorithm platform was designed to make differentiation an engineering problem by using a modified form of CRISPR to turn...

Read More

Driving Innovation in Cell Therapy Manufacturing with Ryan Clarke Syntax Bio

Feb 12, 2026

 Ryan Clarke, Co-Founder and CTO of Syntax Bio, is focused on solving manufacturing challenges in producing stem cell-derived therapies, specifically the process of stem cell differentiation. The Cellgorithm platform was designed to make differentiation an engineering problem by using a modified form of CRISPR to turn...

Read More

Stem Cell Therapy Aims to Rebuild Brain Circuits in Parkinson’s Patients with Dr. Howard Federoff Kenai Therapeutics TRANSCRIPT

Download PDF

Feb 11, 2026

Dr. Howard Federoff, Scientific Co-Founder, Chief Medical Officer, and Executive Vice President of Corporate Medicine and Science at Kenai Therapeutics, is developing a cell therapy for Parkinson's disease that involves transplanting IPSCs into the brain to replace lost dopamine neurons.  The goal is not to cure the...

Read More